Home > Result Summaries: Compounds > albaconazole > Result Summary for 114563

Result Summary for 114563

Result Summary

Protocol ID:	114563
Clinical Study ID:	STF114563
Official Title:	A Phase 1, Randomized, Open-Label, Crossover Safety and Pharmacokinetic Study of 400 mg Albaconazole as a Tablet Formulation Versus a Capsule Formulation in Healthy Subjects
Phase:	phase 1
Study Indications or Diseases:	Onychomycosis
Generic Name:	albaconazole
Trade/Product Name:	albaconazole
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Koen van Rossem & Jenny Lowe. A Phase 1, Randomized, Open-Label, Crossover Safety and Pharmacokinetic Study of 400 mg Albaconazole as a Tablet Formulation versus a Capsule Formulation in Healthy Subjects. Dove Press. 2013;2013:5(1) (January 2013):23 - 31.